Purpose. Several genetic regulators belonging to AraC family are involved in the emergence of MDR isolates of E. aerogenes due to alterations in membrane permeability. Compared with the genetic regulator Mar, RamA may be more relevant towards the emergence of antibiotic resistance.
INTRODUCTION
The worldwide emergence of Multidrug-Resistant (MDR) Gram-negative bacteria is a continuous health problem. This phenomenon is associated with the dissemination of selected clones of MDR bacteria as well as the local genetic adaptation of bacteria under the pressure of antibiotic exposure. Moreover, non-specific resistance mechanisms, such as the modification of membrane permeability, facilitate cross-resistance to unrelated molecules and favor the acquisition of specific resistance mechanisms such as target gene mutations and/or activation of hydrolytic enzymes, resulting in high-level drug resistance [1] [2] [3] .
Enterobacter aerogenes has been recognised as a causative agent of nosocomial infection outbreaks since 1993, particularly in Western Europe. This development was mainly due to the dispersion of an epidemic clone [3] . This event corresponded with the international spread of the Extended-Spectrum b-Lactamase (ESBL) TEM-24 (bla ), located on an epidemic plasmid [4, 5] . Infections caused by this prevalent clone are often undetected at an early stage and consequently their control and treatment have been difficult. Since 2003, E. aerogenes has been considered as an important MDR pathogen, particularly in intensive care units [2] . This observation has been associated with a reduced susceptibility to the most recently developed cephalosporins, including cefepime and cefpirome, and to carbapenems [6] . The alteration of envelope permeability by downregulation of porin expression, modification of lipopolysaccharides, and variation in efflux pump expression levels, has been reported to influence both virulence and strain susceptibility to various compounds [3, 7, 8] . Such adaptations were particularly observed in clinical strains isolated during carbapenem treatment of infections [6, 9] . A longitudinal study of clinical E. aerogenes isolates, collected over an eight-year period, indicated an important role for efflux mechanisms in the emergence of resistance [10] . The efflux pump AcrAB-TolC, identified in E. aerogenes clinical isolates, extrudes a variety of compounds including detergents and structurally unrelated antimicrobial agents such as quinolones, tetracyclines, and chloramphenicol [2] . A strong correlation between AcrAB expression and the genetic regulator RamA was reported previously in E. aerogenes [11] . The same pattern was documented in Klebsiella pneumoniae, Enterobacter cloacae and Salmonella enterica. [12] [13] [14] [15] [16] . Multiple genes and external factors are involved in the emergence of MDR isolates of these three species [15, 17, 18] . This capacity for development of antibiotic resistance has been associated with a regulatory cascade involving the regulators of the AraC family (MarA, SoxS, Rob and RamA) that control the expression of membrane transporters [19, 20] . RamA seems to be more relevant to the development of antibiotic resistance in K. pneumoniae and Salmonella spp. [20] [21] [22] [23] [24] . Key regulatory features of the ramA locus are conserved amongst Klebsiella, Enterobacter, Citrobacter and Salmonella spp [21] . Modification in the expression of global activators can be mediated by mutations or ligand-mediated interactions with the cognate repressor. Various compounds such as salicylate, imipenem or chloramphenicol for marA and chlorpromazine, thioridazine, fluoroquinolones, cefoxitin or paraquat for ramA contribute to the MDR phenotype [20, 25] . In addition, several mutations located in marRAB, ramAR, rob or soxRS in clinical isolates are associated with up-and down-regulation of efflux pump genes; the same pattern has been reported for porin synthesis, respectively [22, [26] [27] [28] [29] [30] . This phenomenon has been observed both in vitro during culture of bacteria in the presence of drugs and in vivo during antibiotic treatment of infected patients [31] [32] [33] .
Mutations arising in specific repressors, MarR and RamR, have commonly been reported to modulate the permeability barrier in bacteria. Resolution of the MarR crystal structure confirmed that it acts as a dimer, which is a common trait of bacterial regulators [34] . Three regions of the MarR repressor are important for its activity: two putative helixturn-helix DNA-binding domains and the first 31 amino acids, which are involved in the dimerization process [35] . Numerous mutations described in several clinical isolates of E. coli are scattered throughout the MarR sequence, and the minimal sequence necessary for function and specificity has not been defined [36] . RamR is a 191 amino acid regulatory protein in which the 50 first amino acids correspond to the DNA-binding domain and the C-terminus is composed of six a-helices, including important regions for dimerization. It belongs to the TetR-family of transcriptional repressors and acts as a dimer on the operator region via palindromic binding sites [20, 21] . Different mutations in ramR have been confirmed to play a role in resistance in Klebsiella and Salmonella spp. Such mutations include deletions that create a premature stop site, resulting in a truncated protein; or other nucleotide deletions in the putative binding site upstream of ramA [23, 28, 30, [37] [38] [39] . Despite these reports the true clinical role of MarA and RamA in the emergence and dissemination of MDR Enterobacter strains may be under-estimated due to the limited number of complete clinical investigations to date. For the most part, only partial and case by case studies have been carried out in this regard [10] .
In this study, we characterised the sequence and function of the RamR repressor of multiple clinical isolates of E. aerogenes. We compared the RamR amino acid sequences of 47 documented MDR clinical strains; 10 strains selected in vitro using defined antibiotics; and two reference strains. Variations in the sequence were identified and their corresponding relationship(s) with the MDR phenotype was investigated in clinical isolates using MIC assays for structurally unrelated antibiotics. Quantitative gene expression of the different regulators and their targets pointed to a key role for RamA in the development of MDR E. aerogenes. We report differences in antibiotic susceptibility and expression of porins and efflux pump components among E. aerogenes strains that overexpress ramA or ramR. These results support the working hypothesis that the ramRA regulon is a key player in control of membrane permeability in Enterobacter spp.
METHODS

Bacterial strains
Fifty nine E. aerogenes strains were investigated: two laboratory reference strains, laboratory induced mutants by treatment with chloramphenicol (CM64) and imipenem (IPM5 to IPM240), and 47 clinical isolates (Table 1 ). All strain characteristics concerning antibiotic susceptibility, outer membrane protein content and activity of an efflux mechanism have been described previously [6, 10, 11, 29] . E. coli strain JM109 was used for all cloning experiments and expression vector construction. All bacteria were cultivated at 37 C in Luria-Bertani (LB) Medium.
Sequencing of marA, marR, ramA and ramR DNA from each bacterial isolate was prepared using the Wizard Genomic DNA Purification Kit (Promega). Purified DNA was then used as a template for PCR and later on for DNA sequencing to detect the presence of mutations in marA, marR, ramA, ramR and their flanking regions. The sequences of the primers are shown in Selection of bacterial mutants by incubation with antibiotics LB agar plates with increasing concentrations of chloramphenicol, rifampicin and fosfomycin were prepared. Twofold dilution series of each antibiotic were prepared, using concentration ranges of 2-64 µg for chloramphenicol and fosfomycin ml À1 and 1-16 µg for rifampicin ml
À1
, according to the Soci et e Française de Microbiologie (http://www. sfm-microbiologie.org). For each antibiotic, 12 colonies of the laboratory strain ATCC13048 were picked and grown under increasing antibiotic concentrations for 24 h at 37 C.
The ramA and ramR genes of the surviving strains at the highest concentration of chloramphenicol (64 µg ml
), fosfomycin (64 µg ml À1 ), and rifampicin (16 µg ml À1 ) were sequenced (GenomicExpress), and compared to identify the mutations that occurred during antibiotic treatment.
Quantitative realtime-PCR Two or three primer pairs were designed to quantify the expression of each gene of interest, which included: ramA and ramR as representatives of the ram-regulon; marA and marR as key players in the mar-regulon; soxR an important gene involved in the oxidative stress regulon [24] ; acrA as a representative component of the efflux pump [33] and omp35 as the gene encoding the major porin involved in antibiotic influx [7, 9] . Each primer pair (Table S2 ) was tested at an annealing temperature of 60 C using a standard PCR protocol to determine the optimal working primer pairs. RNA for quantitative Realtime-PCR was extracted with the RiboPure-Yeast kit (Ambion), and quantified using a NanoDrop spectrophotometer. Contaminating genomic DNA was eliminated by two DNase I treatments according to the manufacturer's instructions (Ambion), and its absence was confirmed by including a reverse transcriptaseminus control for each RNA sample. An Eppendorf epMotion 5070 robot was used to set up the plates and the qRT-PCR was performed using an Eppendorf Mastercycler ep realplex Thermal Cycler.
QuantiTect SYBR Green RT-PCR (Qiagen) was used with a final concentration of 0.5 µM of each primer and 500 ng of the template RNA. After 30 min at 50 C for the reverse transcription, the HotStarTaq DNA Polymerase (Qiagen) was activated by a heating step at 95 C for 15 min. The 3-step cycles of 15 s at 94 C for denaturation, 30 s at 60 C for annealing and 30 s at 72 C for extension were repeated for 35-45 cycles. Each quantitative realtime PCR was repeated three times.
Expression levels of the multi-drug efflux transporter and transcriptional regulator encoding genes were compared and normalised to those of the 16S rRNA housekeeping gene. Relative levels of gene expression, compared to the ATCC13048 strain, were quantified using the 2(-Delta Delta C(T)) method of Livak and Schmittgen [40] . An increase or a decrease of two-fold was defined as a significant effect.
Cloning and expression of ramA and ramR The ramA loci (including the putative marbox) and ramR genes were cloned from characterised strains of E. aerogenes. The ATCC 13048 ramA and ramR were used as an example of genes from susceptible strains, whilst EA27 (ramA27, ramR27) and CM64 (ramA64) were representative of MDR clinical isolates. The CM64 ramA64 gene was identical to the ATCC13048 ramA (data not shown) and therefore was not cloned for this investigation. The CM64 ramR64 gene was the only ramR showing a deletion at position 154/155 and therefore was used to characterise potential effects of this mutation.
All ramA and ramR genes and associated marboxes were amplified by PCR using primers that incorporated restriction sites at each end (detailed in Table S3 ). PrimeStarHS DNA Polymerase (Takara) was used to amplify products by PCR according to the manufacturer's instructions. Purified PCR-products were digested using XhoI and SacI (ramR) or BamHI and EcoRI (ramA) (New England Biolabs) and cloned into the expression vector pDrive (3851 bp) (Qiagen), using T4 ligase (NEB) to create pDriveramA-ATCC13048, pDriveramA-EA27, pDriveramR-ATCC13048, pDriveramR-EA27, and pDriveramR-CM64. Plasmid constructs were transformed into an electrocompetent E. coli JM109 strain. Plasmid constructs were purified and confirmed by sequencing (GenomeExpress), using the primer pair T7 and SP6 (Eurogentec). Each of the 5 plasmids was then transformed separately into E. aerogenes ATCC13048 (representative of non-MDR strains); EA289 (a kanamycin susceptible derivative of EA27, that represented more than 90 % of MDR clinical isolates); CM64 (a laboratory mutant chosen for the specific deletion in RamR at positions 154/ 155), and IPM240 (a laboratory strain sequentially exposed to increasing imipenem concentrations and possessing ramA and ramR genotypes that were associated with a MDR phenotype) [6] . Bacterial transformants carrying the pDriveIV plasmid were grown in the presence of antibiotics: E. coli with 100 µg ml À1 of ampicillin (Sigma) and E. aerogenes with 50 µg ml À1 kanamycin (Sigma).
Minimal inhibitory concentration (MIC)
determination by E-Test stripes ATCC13048, EA289, CM64, and IPM24 plasmid-containing strains were grown to OD 600 0.4 in LB containing appropriate antibiotics and then induced with IPTG (1 mM) for 1 h at 37 C. Bacteria were then sub-cultured into fresh broth and grown to OD 623 0.35 (approximately 10Â10 8 colony forming units ml
À1
). Induced cultures were diluted to 10Â10 6 c.f.u ml
, and spread (2.5 ml) on LB agar plates containing 0.5 mM IPTG. After drying for several minutes, E-Test stripes were placed on the plates and bacteria grew in presence of the tested antibiotics (ciprofloxacin, norfloxacin, nalidixic acid, tetracycline, chloramphenicol, imipenem, cefoxitin, cefuroxime, cefepime and ceftazidime) over night at 37 C. Assays were independently repeated three times.
SDS-PAGE and Western blotting
Bacterial protein extracts were analysed by SDS-PAGE using 10 % acrylamide. Samples were denatured in Laemmli loading dye containing 2 % SDS and the protein-samples were heated three times at 95 C. Protein size was estimated by comparison with pre-stained low-range molecular weight markers (BioRad). Proteins were stained using Coomassie Brilliant Blue R-250 as previously described [6] .
For immunodetection, proteins were electro-transferred onto nitrocellulose membranes (Schleicher and Schull Bioscience) in transfer buffer (20 mM Tris, 150 mM glycine, 20 % isopropanol, 0.05 % SDS). Membranes were blocked using 4 % milk in Tris-buffered sodium (TBS: 50 mM TrisHCl, 150 mM NaCl, pH8). Polyclonal antibodies (Neosystem), directed against denatured proteins (i.e. AcrA, AcrB and TolC), were used for detection [6, 10, 11] . Quantitation of the antigen-antibody complexes was performed with alkaline phosphatase-conjugated AffinitiPure goat antirabbit IgG antibodies (Jackson ImmunoResearch) using BCIP and NBT (Sigma) according to the manufacturer's instructions [11] .
RESULTS
Variability in regulators involved in resistance of clinical isolates
The marA, marR and ramA gene sequences of all E. aerogenes strains, investigated for this study, were identical to those of the susceptible ATCC13048 strain. However, 93.6 % (44/47) of the MDR clinical isolates, showed a deletion in the upstream region of ramA, proximal to the marbox (Fig. 1 ).
Several amino acid-level changes were detected in the ramR sequences of MDR clinical isolates compared to laboratory strains. The majority of clinical isolates (97.8 , 93.6 and 97.8 % respectively) exhibited substitutions at positions 72 (Ala to Asp); 100 (Pro to Ser) and 121 (Ile to Ser). Compared with the ATCC13048 strain 93.6 % (44/47) of the clinical isolates also contained an altered C-terminus, corresponding to a four amino-acid deletion. These mutations were located outside the putative DNA-binding area that corresponds to the 50 first N-terminal amino acid. Such mutations may alter the three dimensional structure of the repressor, taking into account the type of substituted side chains that have different charges and sizes compared to the original [41] . Stepwise increasing concentrations of chloramphenicol were used to select for the resistant laboratory strain CM64. When analysed, the sequence of its ramR64 gene showed unique amino acid deletions at positions 154 (Leu) and 155 (Phe) [8] . No other strain showed such deletion.
In vitro selection of mutants can affect ramR structure and function To determine whether the characteristic deletion at position 154/155 in ramR64 was reproducible, the ATCC13048 strain was grown under the same increasing chloramphenicol concentrations as were used to create CM64. For further verification and to determine whether new mutations would emerge, rifampicin and fosfomycin were also used in the same way, to select for resistant mutants. These antibiotics (chloramphenicol, rifampicin, and fosfomycin) are known for their capacity to select mutants at high frequency. The ramA and ramR genes of mutants, surviving sequential increasing antibiotic treatments, were sequenced. All tested strains produced mutants that survived stepwise treatment with high concentrations of rifampicin (up to 16 µg ml À1 ) and fosfomycin (up to 64 µg ml À1 ), and 67 % (8/12) produced mutants that survived exposure to high levels of chloramphenicol (up to 64 µg ml À1 ). None of the fosfomycin or rifampicin resistant mutants showed variation in ramA or ramR sequences compared to the ancestral strains (data not shown). One of the eight chloramphenicol selected mutants (CM64new-10) harbored an interesting mutation in ramR, which introduced a stop-codon at position 27 ( Fig. 2) .
Characterisation and validation of expression of regulators of the MDR phenotype by qRT-PCR
Realtime qPCR was used to compare the levels of expression of key genes involved in E. aerogenes responses to antibiotic treatments and involved in the Mar and Ram regulation cascades ( Table 2 ). The clinical isolate RAB76089G and the two imipenem resistant strains, IPM20 and IPM240, did not exhibit any significant change in expression profile compared to the reference ATCC13048 strain for all target genes (marA, marR, ramA, ramR, soxR, acrA and ompA): with the exception of RAB76089G, that showed a 2.88 fold decrease in marR expression ( Table 2 ). All other clinical isolates (EA27, EA117, EA3, EA5, GIM55621, GIM59704, MOK75586 and PAP12515) and the laboratory mutant CM64 showed a marked increase in the expression of the transcriptional activator, ramA ranging from >14 fold increase (PAP12515) to >140 fold increase for the chloramphenicol mutant CM64. The putative repressor of the ramregulon, ramR, was also highly expressed by clinical isolates compared to the reference ATCC13048 strain, but ramR expression was considerably weaker than ramA expression in the same isolate. Relative ramA expression levels ranged from >2 fold (GIM59704) to >10 fold (CM64). The exception was EA5 that showed >3 fold decreased expression of ramR compared to ATCC13048. Three clinical isolates (EA117, EA3 and EA5) exhibited significantly increased expression of the mar regulon genes (marA and marR), and soxR (ranging between >20 fold to >160 fold increase). The remaining strains showed only marginal variations in expression that were not significantly different to the reference strain.
The majority of MDR clinical isolates were found to be upregulating expression of the efflux pump component acrA (up to a 3-fold increase) and downregulating expression of the major porin gene omp35 (down to a 9-fold decrease). IPM20 and IPM240 mutants, selected using sequentially increased concentrations of imipenem, showed similar expression of the tested genes to the reference ATCC13048 strain. This can be explained by the lack of imipenem selective pressure used during growth of these cultures for the qRT-PCR experiments.
Overexpression of ramA or ramR can regulate the expression of efflux pump components and outer membrane porins Construction of strains that over-expressed ramA or ramR, and immune-detection of key membrane permeability components, corroborated the associated variation observed in gene expression at the protein level. Western blot analysis showed significant variations in the expression of major porins (Omp35 and Omp36) and components of efflux pumps (AcrA, AcrB, TolC) in several strains that over- expressed ramA or ramR. A notable decrease in porin protein expression was observed in protein extracts from transformed strain EA27 that over-expressed ramA from ATCC13048 and EA27. By contrast, when the same strain was modified to over-express ramR from ATCC13048, EA27 and CM64 a small increase in porin protein expression was observed (Fig. 3) . At the same time, no variation of the OmpA, an outer membrane protein involved in the membrane organisation, was observed [2] . Similar effects were observed for strains EA289, CM64, and IPM240 that over-expressed ramA (data not shown). Overexpression of ramR in ATCC13048 showed no alteration of the porin content, regardless of the ramR origin (data not shown).
The effects of ram gene over-expression on the production of the efflux pump components (AcrA, AcrB, and TolC) are also presented in Fig. 3 . Both ramA of ATCC13048 and EA27 induced a small increase in AcrA expression, along with AcrB and TolC in EA289, CM64 and IPM240. Overexpression of ramR from ATCC13048, EA27, and CM64 had the opposite effect and generated significant decreases in the signals of efflux pump components in the three tested strains. No variation of efflux pump components was observed in the strain ATCC13048 when ramR was overexpressed (data not shown).
Involvement of RamA overexpression on the antibiotic phenotype Both ATCC13048 and the imipenem-selected mutants (IPM20 and IPM240) exhibited a significant change in their antibiotic susceptibility profiles when ramA was overexpressed. Table 3 shows that the ATCC13048 strain presented increased resistance to a nalidixic acid tetracycline, and chloramphenicol (6-fold higher MIC), and to cefepime (4-fold higher MIC). The strain IPM240 showed increases in resistance to nalidixic acid and tetracycline. Fig. 2 . Comparison of the amino-acid sequence of RamR identified in 2 variants of the ATCC13048 reference strain, obtained after treatment with chloramphenicol; CM64 was characterised previously [43] and CM64 new-10 was identified form the stepwise treatment with chloramphenicol. Overexpression of ramA had only slight effects in already MDR-strains EA289 and CM64 (data not shown).
Involvement of ramR overexpression on the antibiotic phenotype of a strain selected under increasing concentration of imipenem E-Test strip analysis of the imipenem-selected mutant IPM240, that had been modified to over-express ramR from three different sources (ATCC13048, EA27, and CM64), resulted in a nearly three-fold decrease in the minimum inhibitory concentration of imipenem from 32 to 12 µg ml À1 (Table 4) . A significant decrease in the MICs was also observed for tetracyclin and chloramphenicol.
Overexpression of ramR in EA289 and CM64 resulted in only minor effects and no effect at all was observed when the various ramR genes were over-expressed in ATCC13048 due to a native inhibition in this strain (data not shown).
DISCUSSION
Numerous regulators have been described in the development of bacterial MDR and both structural and genetic investigations endeavor to understand and decipher their mechanisms of action [14, 18, 19] . Enterobacteriaceae have evolved different molecular resistance strategies in response to a variety of toxic compounds and environmental stresses by way of the membrane permeability modulation, which is Fig. 3 . Expression of AcrA, AcrB, TolC and Omp36 in Enterobacter aerogenes strain EA289 harboring different plasmids. Lines 1-6 : 1 empty plasmid pDriveIV, 2 insert ramA ATCC, 3 ramA EA27, 4 ramR ATCC, 5 ramR EA27 and 6 ramR CM64. Increased expression respectively of AcrA, AcrB, TolC due to overexpression of ramA marked with stars *, decrease due to ramR marked with ¤. Lowered expression of omp36 due to overexpression of ramA marked with stars *. associated with the expression of drug transporters including porins and efflux pumps. The control of their expression is carried out at several levels: global or local regulators, activators, repressors and response to chemical or pharmaceutical factors [3] .
One positive regulator of growing interest in E. aerogenes is the global transcriptional activator RamA that is known to be involved in the balance of outer membrane permeability and in the active extrusion of intracellular antibiotics. RamA shares high similarity with MarA and it can be expected that ramA and marA might recognise an overlapping set of operator sequences. Previous reports have revealed that mutations or gene interruptions could be acquired either within ramR or in the ramA promoter [23] .
In the present study, sequence analysis of various MDR strains of E. aerogenes revealed the presence of several mutations in ramR that were located outside the region involved in the DNA-binding domain of TetR family repressors, they were found in the C-terminus, that was associated with protein dimerization.
These ramR mutations have not previously been described in E. aerogenes or in other related species, such as S. enterica, K. pneumoniae, and E. cloacae [22-24, 28, 33, 37, 39-42] . These mutations could induce structural changes, inactivating the RamR repressor function. The deletion upstream of ramA was located between the gene and the putative marbox, responsible for self-regulation of the gene. The binding site of RamR contains essential features of the ramA promoter, including the À10 conserved region, the transcriptional start site of ramA and two 7 bp inverted repeats [23] . Modifications here could alter protein-DNA binding and hence the self-regulation of ramA. Both detected modifications could therefore be responsible for the increased expression of ramA that consequently trigger the MDR phenotype. It has been previously demonstrated that sequence alterations in ramR or in the upstream region of ramA led to an up-regulation of AcrAB in Salmonella enterica [31, 43] . A characteristic deletion at position 154/ 155 in ramR was only found in a chloramphenicol-resistant mutant (CM64) that was selected for with increasing concentrations of chloramphenicol [8, 44] . A mutation in the repressor causing increased expression of the global activator might bring benefits for bacterial survival in an otherwise hostile environment.
Expression patterns of marA and marR indicated that a balance between expression of activators and repressors takes place in E. aerogenes resistant isolates. An increased expression of RamR, that does not affect expression of ramA, indicated that the repressor would be less functional, probably as a result of the detected mutations. After growing in the absence of antibiotics, the E. aerogenes strains rapidly reregulated membrane permeability and showed the same expression patterns as the susceptible reference strain ATCC13048. In contrast, the expression pattern of the chloramphenicol resistant mutant CM64, exhibiting a deletion in ramR, was comparable with those of the clinical isolates. The clinical isolates showing a MDR phenotype also exhibited a decreased transcription of porin gene (omp35) and an increased expression of the efflux pump gene, acrA.
These results depicted a consistency between the increased expression of both ramA efflux pumps, and the decreased expression of porins that triggers the MDR phenotype in clinical isolates. Some MDR clinical isolates showed increased expression of omp35 that can be balanced out by the post-transcriptional control of porin genes or the posttranslational control of porin assembly into the bacterial outer membrane [8] . In contrast, the expression of marA remained on a comparable level with the susceptible reference strain. As suggested by Wang et al. in K. pneumoniae, MarA might serve as an alternative regulator and RamA would be the most potent regulator of the MDR phenotype [21, 42] . This observation points to the importance of the global regulator ram for the MDR-phenotype in E. aerogenes. However, Martin et al. compared activation of a set of promoters containing marboxes, depending of MarA or SoxS concentration [19] . They observed that the half maximal activation of promoters by MarA was highly concentration dependent, and correlations between in vivo and in vitro experiments measuring optimal activator concentration were poor, and the promoter activation profile depends specifically on the activator. So target gene activation is thought to depend on the concentration and the nature of a given activator of the mar regulon. [15] . This is supported by the existence of alternate pathways in ramA regulation as the level of other regulators and the intracellular concentration-dependent response of the bacterium to increasing overexpression of the transcriptional activator [20, 41] . Conversely, diverse mutations in RamR were able to stimulate identical ramA overexpression as previously demonstrated [42] . Moreover, considering the reported influence of RamA on more than 100 genes, the combination of their level of expression could result in a panel of pleiotropic MDR phenotypes [20] . Regarding the strain CM64 that presented a particular deletion in RamR, expression of ramA was increased by more than 100-fold compared to the others, suggesting that this deletion was more important in the regulation cascade. Importantly, the MDR phenotype of CM64 was not particularly different, a feature that makes it difficult to further elucidate their role in functional changes in ramR.
Rosenblum et al. observed that in K. pneumoniae, RamR mutations could be found in both DNA and ligand binding domains, suggesting that there were no mutational hotspots within RamR [24] . Moreover, it has been demonstrated that several mutations are required for MarR inactivation, so as to obtain a significant alteration of its repressor activity [23, 24, 30, 35, 36] . Genes regulated by RamA seemed to be controlled by it in a concentration-dependent manner, as observed by qRT-PCR experiments and Western blotting results.
The MDR phenotype in E. aerogenes is caused by several factors acting in concert. The combination of an enzymatic barrier caused by several antibiotic-degrading enzymes, a target-protection barrier caused by mutations in the targets of antibiotics, and the physical barrier by alteration of the outer membrane profile, work together to protect the bacteria from harmful substances. Alteration of just one of these barriers will not switch off MDR. This feature is supported by the fact that overexpressed ramA or ramR alter the membrane profile of the tested MDR strains by increasing or decreasing the expression of porins or efflux pump components as shown by immunoblot analysis, but the E. aerogenes susceptibility to various antibiotics was not completely modified, as shown by MIC data. The strain EA289 remained resistant to the majority of the tested antibiotics because the enzymatic and the target protection barrier are insensitive to the overexpression of ramA or ramR [1, 3] . The reason that the chloramphenicol-selected mutant, CM64 maintained its MDR phenotype, despite over-expression of ramR could not be determined in this study. Since chloramphenicol induced a high mutation rate, we cannot eliminate the possibility that the CM64 mutant possesses mutations in other loci. These mutations could also contribute to the MDR phenotype. The fact that ramR did not have any effect on the already antibiotic susceptible strain ATCC13048 can be explained by the normal production of ramR in the susceptible strain. An overexpression of ramA on the other hand may contribute to an imbalance in the ratio between activator ramA and repressor ramR, thereby altering membrane permeability and thus increasing resistance to several antibiotics as shown by the MIC data.
To conclude, this study demonstrated that the global regulator ram is important in the cascade of membrane permeability. The mutations identified in ramR seem to modify the structure of the protein required for the affinity of the binding site as previously reported for MarR and TetR repressor family and hereby leave it less functional compared to the wild-type [25, 43] . In addition, the activity of the global regulator also depends on its expression level. Overexpression of a less functional repressor is able to modify the content of porins and efflux pumps in the outer membrane. Finally, this was the first study to provide data describing the direct correlation between the expression of genes constituting the ram-regulon and their respective influence on membrane permeability in E. aerogenes.
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